Four numbers, three of them widely misunderstood, and one of them often not measured at all.
A standard lipid panel gives you four lines: total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides. Most reports add a fifth, non-HDL cholesterol, and some add a ratio. Only three of the four are actually measured.
Cholesterol is a fat. Blood is water. Fat does not dissolve in water, so the body packages it inside particles with a protein shell — lipoproteins — and ships it that way. LDL and HDL are not kinds of cholesterol. They are kinds of delivery van, and the panel is measuring how much cargo each fleet is carrying.
This distinction stops being pedantic the moment you look at ApoB, further down.
Most laboratories do not measure LDL directly. They measure total cholesterol, HDL and triglycerides, then derive LDL with an equation — the Friedewald formula, or one of its newer refinements.
The equation makes an assumption about how cholesterol is distributed, and the assumption breaks when triglycerides are high. Above roughly 400 mg/dL (4.5 mmol/L), a calculated LDL is not trustworthy and most laboratories will say so on the report or decline to give one. Above about 150 it is already drifting.
If your triglycerides are raised, a calculated LDL that looks reassuring is the single most common way a lipid panel misleads somebody.
HDL carries cholesterol away from tissues and back to the liver, and low HDL is a consistent marker of raised cardiovascular risk. That much is settled.
What is not settled is the reverse. Raising HDL with drugs has repeatedly failed to reduce events in trials, and very high HDL — above roughly 90 mg/dL — is associated with worse outcomes, not better. HDL is a good thermometer and a poor thermostat.
Triglycerides are the body's circulating fuel store, and they respond fast — to a meal, to alcohol, to a few bad weeks. They are also the lipid most tightly linked to insulin resistance, which is why a raised triglyceride with a low HDL is a recognisable pattern rather than two separate findings.
Modern guidance no longer requires fasting for a routine lipid panel, because LDL and HDL barely move with a meal. Triglycerides do. If you are tracking triglycerides specifically, fast, and fast the same way each time.
Non-HDL cholesterol is total cholesterol minus HDL. One subtraction, no assumptions, no equation to break. It captures every particle that can deposit in an artery wall, not just LDL.
Because it needs no calculation, it stays valid when triglycerides are high — exactly the situation where LDL stops being reliable. If your report gives it, it is often the more honest line of the two.
Every atherogenic particle carries exactly one apolipoprotein B molecule. So ApoB counts particles, where LDL cholesterol weighs their contents.
Two people can carry identical LDL cholesterol while one has many small particles and the other has fewer large ones. The first is at higher risk, and only ApoB distinguishes them. It is a separate test, it costs more, and it is increasingly the number cardiologists ask for. It is worth knowing it exists.
Look at triglycerides first, because they tell you whether to trust the LDL beneath them. Then look at non-HDL. Then look at the trend, if you have one.
What any of it means for your own risk depends on your blood pressure, your glucose, your family history and your age, which is why a lipid panel is read alongside everything else rather than on its own.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers